In Luminal A breast cancers, the positive survival effects of AMPK, MARK3, PAK1, BRSK1, SNRK, and QSK are maintained in the pre-chemotherapy but not in the post-chemotherapy cohorts. Here, PRKAA1 is linked to breast carcinoma.